A couple of weeks ago I compiled the ShareTalk Top 20 Stocks Of The Year 2020. It has been a tough year emotionally and otherwise for most of us.
A couple of weeks ago I compiled the ShareTalk Top 20 Stocks Of The Year 2020. It has been a tough year emotionally and otherwise for most of us.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Phase 1b/2 Clinical Trial – Crohn’s Disease
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
Tiziana Announces Initiation of Clinical Trial for COVID-19 Patients in Brazil with Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed pharmaceutical stocks on the small-cap London market and gives an overview in this video charting update.
London, New York, 26 October 2020 – Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.